quinazolines has been researched along with pirarubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borowski, E; Garnier-Suillerot, A; Seksek, O; Stefanska, B; Tarasiuk, J; Tkaczyk-Gobis, K | 1 |
| Arciemiuk, M; Bontemps-Gracz, MM; Borowski, E; Głowacka-Rogacka, D; Kupiec, A; Tarasiuk, J | 1 |
2 other study(ies) available for quinazolines and pirarubicin
| Article | Year |
|---|---|
Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.
Topics: 3T3 Cells; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Nucleus; DNA; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Genes, MDR; Humans; K562 Cells; Lysosomes; Mice; Quinazolines | 2001 |
The activity of latent benzoperimidine esters to inhibit P-glycoprotein and multidrug resistance-associated protein 1 dependent efflux of pirarubicin from several lines of multidrug resistant tumor cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzene Derivatives; Doxorubicin; Drug Resistance, Multiple; Humans; Immunosuppressive Agents; Quinazolines; Tumor Cells, Cultured | 2004 |